Ken Kasahara, Takeyuki Kono, Yoichiro Sato, Keisuke Okubo, Seiji Shigetomi, Ayaka Sasaki, Ko Hentona, Yutaro Mokudai, Keigo Oguchi, Motoki Izawa, et al. Risk-benefit stratification for immune checkpoint inhibitor therapy in head and neck cancer based on immune-related adverse events and treatment discontinuation using routine clinical indicators beyond PD-L1 expression. Oral oncology. 2026. 176. 107938-107938
Kasahara, K., Mikoshiba, T., Idei, K., Matsui, Y., Kono, T., Sekimizu, M., Ozawa, H. Prognostic impact of MRI-based cervical skeletal muscle mass on survival in parotid gland carcinoma. JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2026
Sekimizu, M., Mikoshiba, T., Nagai, R., Ishikawa, N., Okada, T., Kitayama, M., Kawakita, D., Nibu, KI, Yoshimoto, S., Ozawa, H. Nationwide analysis of olfactory neuroblastoma in Japan: evolving treatment approaches and prognostic outcomes. JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2026. 56. 3. 282-289
Masafumi Ueno, Makoto Hosoya, Hirotaka So, Nobuyoshi Tsuzuki, Marie N Shimanuki, Takanori Nishiyama, Hiroyuki Ozawa, Naoki Oishi. A marked decrease in speech intelligibility is no longer a major characteristic of vestibular schwannoma in the current era. Clinical and experimental otorhinolaryngology. 2026
Kasahara K., Kono T., Sato Y., Okubo K., Sasaki A., Hentona K., Mokudai Y., Oguchi K., Izawa M., Shinden S., et al. The prognostic impact of sarcopenia and systemic inflammation in head and neck cancer patients treated with immune checkpoint inhibitors. Auris Nasus Larynx. 2026. 53. 1. 1-6
